Literature DB >> 30142837

Inflammatory myofibroblastic tumors in the kidney and abdominal wall mimicking malignancy: A case report.

Yiqiu Wang1, Xiaokang Qi, Peng Xue, Chunfang Zhang, Chengkuan Cai, Chuanquan Tu, Kunpeng Wang.   

Abstract

RATIONALE: Inflammatory myofibroblastic tumor (IMT) is uncommon, coexistence of IMTs in the kidney and abdominal wall are more uncommon. PATIENT CONCERNS AND DIAGNOSIS: We report a 74-year-old female who presented with 6 months history of left flank pain and approximately 5 kg weight loss that were diagnosed as renal cell carcinoma and locally metastatic abdominal wall tumor. INTERVENTIONS AND OUTCOMES: A left radical nephrectomy and excision of the abdominal wall tumor were done. The pathologic result was IMTs. After follow-up for 66 months, the patient showed no signs of tumor recurrence. LESSONS: Coexistence of IMTs in the kidney and abdominal wall is extremely rare and is often diagnosed as malignancy. Therefore, IMTs should be considered in the diagnosis of the patient with both kidney and abdominal wall tumors.

Entities:  

Mesh:

Year:  2018        PMID: 30142837      PMCID: PMC6112863          DOI: 10.1097/MD.0000000000011994

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Inflammatory myofibroblastic tumor (IMT) is a rare pathologic entity that was originally described in the lung. Extrapulmonary IMTs, including the gastrointestinal tract, urinary tract, mesentery, paratesticular tissue, etc, have also been reported.[ In the urinary tract, it occurs most often in the bladder while rarely in the kidney.[ Similarly, only 3 cases of IMTs that originate from the abdominal wall have been reported.[ As far as we know, there is no report about IMTs of the kidney combined with abdominal wall in the literature previously. Herein, we report an IMT in a 74-year-old female that was misdiagnosed as renal cell carcinoma and locally metastatic abdominal wall tumor.

Case presentation

In October 2012, a 74-year-old female presented with 6 months history of left flank pain and approximately 5 kg weight loss. She underwent cholecystectomy 23 years ago because of the gall bladder stone. Physical examination demonstrated slight left renal percussive pain. Basic laboratory examination was nonspecific. Ultrasonography (US) revealed a 7 cm × 8 cm slight hyperechoic mass at the upper pole of the left kidney and severe hydronephrosis, but negligence of the left abdominal wall mass due to the interference of the twelfth rib and the gas in the intestinal cavity. Computed tomography (CT) revealed a 7 cm × 8 cm heterogeneous mass attached to the spleen and pancreas and located at the upper pole of the left kidney including a 3 cm × 4 cm left abdominal wall mass. A contrast-enhanced CT scan was done (Fig. 1). The masses were significantly enhanced, indicating of malignancy. And renal cell carcinoma and locally metastatic abdominal wall tumor were diagnosed. Therefore, a left radical nephrectomy and excision of the abdominal wall tumor were planned. The upper pole of the kidney tumor is slightly harder, about 7 cm × 8 cm in size, and closely adheres to the tail of the pancreas. Considering that it is a malignant tumor, it is difficult to remove the pancreatic tail and preserve the spleen. Therefore, the combined pancreatic tail and spleen were removed. After the exploration of the abdominal wall, a solid red mass of approximately 3 cm × 4 cm was probed on the dorsal abdominal wall of the twelfth rib. The texture was slightly stiff and adhered tightly to the abdominal wall, and the abdominal wall mass was completely resected by blunt and sharp separation.
Figure 1

(A) CT showed a mass in the left of the kidney (arrow). (B) Contrast-enhanced CT showed the mass was attached to the spleen and pancreas tightly. (C, D) The masses were significantly enhanced.

(A) CT showed a mass in the left of the kidney (arrow). (B) Contrast-enhanced CT showed the mass was attached to the spleen and pancreas tightly. (C, D) The masses were significantly enhanced. Microscopic examination revealed typical spindle cell proliferation with inflammatory cells (Fig. 2). Immunohistochemistry showed S-100 was positive, smooth muscle actin, desmin, and ki-67 (10%) were focally positive, but cytokeratin was negative. Pathological diagnosis of IMTs in the left kidney and abdominal wall was done. The patient recovered well. CT scan at 6, 12, and 36 months showed no evidence of metastatic or recurrent disease (Fig. 3).
Figure 2

The microscopic examination revealed a proliferation of typical spindle-shaped cells accompanied by inflammatory cells (H&E × 400).

Figure 3

Follow-up for 6 months (A) and 36 months (B), CT imaging showed no evidence of recurrence.

The microscopic examination revealed a proliferation of typical spindle-shaped cells accompanied by inflammatory cells (H&E × 400). Follow-up for 6 months (A) and 36 months (B), CT imaging showed no evidence of recurrence.

Discussion

IMT is a rare entity that tends to aggressive behavior and local recurrence, which shows a preference for visceral soft tissue in children and young people.[ Histologically, IMT is characterized by proliferation of typical spindle-shaped cells accompanied by inflammatory infiltration of plasma cells, eosinophils, and lymphocytes.[ The pathogenesis and etiology of IMT are still unknown.[ In some cases, IMT is thought to be caused by trauma and surgery-related infections, or related to other malignancies.[ Some have described it to be related with chronic hepatitis B infection,[ while others have been found it to be related with Epstein–Barr (EB) virus.[ In our case, the patient is a nurse, nonsmoker, with no history of trauma and chronic hepatitis B infection. After the pathological report, we tested the patient's blood for EB virus and the test result was negative. According to the above results, we considered that no special history was related to the development of IMT in our case. Generally, the symptoms depend on the size and location of the tumor. Some patients are with systemic symptoms such as fatigue, fever, or weight loss, while in the urinary tract, hematuria, flank pain, and dysuria are more common. The clinical symptoms of abdominal IMT include abdominal mass, abdominal discomfort, weight loss, and fever.[ In our case, the patient had left flank pain and approximately 5 kg weight loss, which provided the clue for the further examination. There is almost no obvious abnormality in laboratory tests.[ US, CT, and magnetic resonance imaging may allow early diagnosis. However, the diagnosis of IMT is often delayed for its nonspecific and different clinical presentations. In our case, US and CT revealed a mass in the left kidney and a left abdominal wall mass. The tumors were significantly enhanced, which typically indicative of malignant lesions. Surgery with radical excision is still considered to be the best treatment, although steroid therapy has been reported to regress IMT.[ In the present case, the preoperative diagnosis was renal cell carcinoma and locally metastatic abdominal wall tumor. Because the mass was large and attached to the spleen and pancreas tightly, a left radical nephrectomy and excision of the abdominal wall tumor combined with splenectomy and the tail of pancreas resection were carried out. However, histopathological diagnosis was IMTs. After a follow-up for 66 months, the patient does not have recurrence. As reported, the overall recurrence rate of IMT is from 2% to 60%, and the metastatic rate is no more than 5%.[ However, there was no identified potential for recurrence or metastases in the renal IMTs according to the case report.[ IMT can happen in any location, especially in abdominopelvic region, retroperitoneum, and lung.[ In the current case, the presence of IMTs in kidney and abdominal wall may indicate a simple incidental coexistence or 1 tumor is metastases from another. To date, only IMTs of the kidney and bilateral lung nodules in a child were reported.[ We do not know whether the abdominal wall of IMT is metastases or synchronized lesions. We consider that the occurrence of the tumors in 2 locations may be 1 tumor is metastases from another or a simple incidental coexistence. The relationship between the tumors needs further investigation in our case.

Conclusion

Coexistence of IMTs in the kidney and abdominal wall is extremely rare, which is easily diagnosed as renal cell carcinoma and locally metastatic abdominal wall tumor. Here, we first report a case of IMTs in the kidney and abdominal wall in the literature. We suggest that the presence of IMTs in the kidney and abdominal wall should be considered in the diagnosis of renal cell carcinoma and locally metastatic abdominal wall tumor.

Acknowledgment

We thank Gang Yuan for providing imaging support.

Author contributions

Conceptualization: Xiaokang Qi. Data curation: Xiaokang Qi, Kunpeng Wang. Investigation: Xiaokang Qi. Resources: Peng Xue, Chunfang Zhang. Software: Chengkuan Cai. Supervision: Peng Xue, Chuanquan Tu, Kunpeng Wang. Validation: Chunfang Zhang, Chengkuan Cai. Writing – original draft: Yiqiu Wang. Writing – review & editing: Yiqiu Wang, Kunpeng Wang.
  18 in total

1.  [Inflammatory myofibroblastic tumour of the abdominal wall in an adult patient].

Authors:  Adriana Hernández López; Alberto Mitsuo León Takahashi; Jorge Monges Jones; Carlos Michel Cárdenas Salomon
Journal:  Cir Esp       Date:  2011-02-18       Impact factor: 1.653

Review 2.  Epstein-Barr virus positive inflammatory pseudotumor of the liver: report of a challenging case and review of the literature.

Authors:  Yan You; Haipeng Shao; Katherine Bui; Marilyn Bui; Jason Klapman; Quancai Cui; Domenico Coppola
Journal:  Ann Clin Lab Sci       Date:  2014       Impact factor: 1.256

3.  Gastric inflammatory pseudotumor in children.

Authors:  C K Maves; J F Johnson; K Bove; R L Malott
Journal:  Radiology       Date:  1989-11       Impact factor: 11.105

4.  Pulmonary inflammatory pseudotumour in children.

Authors:  T Patankar; S Prasad; A Shenoy; K Rathod
Journal:  Australas Radiol       Date:  2000-08

5.  Primary renal inflammatory myofibroblastic tumor.

Authors:  Noppadol Larbcharoensub; Napawan Chobpradit; Kittinut Kijvikai; Panas Chalermsanyakorn
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

Review 6.  Inflammatory myofibroblastic tumor in children: diagnosis and treatment.

Authors:  I Karnak; M E Senocak; A O Ciftci; M Cağlar; M Bingöl-Koloğlu; F C Tanyel; N Büyükpamukçu
Journal:  J Pediatr Surg       Date:  2001-06       Impact factor: 2.545

Review 7.  Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases.

Authors:  Linda R Kapusta; Mark A Weiss; Jennifer Ramsay; Antonio Lopez-Beltran; John R Srigley
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

8.  Inflammatory Myofibroblastic Tumor of the Kidney and Bilateral Lung Nodules in a Child Mimicking Wilms Tumor With Lung Metastases.

Authors:  Mehmet S Dogan; Selim Doganay; Gonca Koc; Sureyya B Gorkem; Ekrem Unal; Figen Ozturk; Abdulhakim Coskun
Journal:  J Pediatr Hematol Oncol       Date:  2015-08       Impact factor: 1.289

9.  Inflammatory pseudotumor of the liver masquerading as hepatocellular carcinoma after a hepatitis B virus infection: Report of a case.

Authors:  Tomotaka Akatsu; Go Wakabayashi; Akihiro Tanimoto; Kaori Kameyama; Masaki Kitajima
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

10.  Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases.

Authors:  C M Coffin; J Watterson; J R Priest; L P Dehner
Journal:  Am J Surg Pathol       Date:  1995-08       Impact factor: 6.394

View more
  2 in total

1.  Non-Wilms' renal tumors in children: experience with 139 cases treated at a single center.

Authors:  Yi Wei Fang; Hong Cheng Song; Ning Sun; Wei Ping Zhang
Journal:  BMC Urol       Date:  2022-06-22       Impact factor: 2.090

2.  Kidney inflammatory myofibroblastic tumor masquerading as metastatic malignancy: A case report and literature review.

Authors:  Guo-Hui Zhang; Xiao-Yan Guo; Gao-Zhao Liang; Qing Wang
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.